| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.900 | strong | 1.000 | 14 | 0 | 1998 | 2018 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.620 | strong | 1.000 | 2 | 0 | 2005 | 2017 | ||||||||
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.500 | None | 0.895 | 19 | 1 | 1987 | 2016 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.490 | limited | 1.000 | 9 | 3 | 1995 | 2018 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.997 | 375 | 0 | 1987 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.400 | None | 0.958 | 47 | 1 | 1994 | 2016 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.400 | None | 0.947 | 35 | 2 | 1997 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 35 | 0 | 1992 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 28 | 1 | 2003 | 2019 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 26 | 0 | 1985 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | strong | 0.962 | 25 | 1 | 2005 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.400 | None | 1.000 | 22 | 1 | 1993 | 2019 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
disease | 0.400 | None | 1.000 | 19 | 1 | 2001 | 2018 | ||||||||
|
ETS transcription factor ERG | 0.453 | 0.808 | 0.96 |
|
disease | 0.400 | None | 1.000 | 13 | 0 | 1994 | 2019 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.400 | None | 1.000 | 13 | 0 | 1998 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 1992 | 2018 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.833 | 10 | 0 | 1998 | 2018 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.846 | 8 | 0 | 1999 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
disease | 0.390 | None | 1.000 | 9 | 0 | 2014 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.370 | None | 1.000 | 7 | 5 | 1991 | 2018 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 1998 | 2020 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 1984 | 2019 | ||||||||
|
DNA ligase 4 | 0.478 | 0.846 | 4.2E-06 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 1999 | 2014 | ||||||||
|
polo like kinase 1 | 0.467 | 0.808 | 0.98 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2009 | 2019 |